Hormonal
Transitioning from a very-low-carbohydrate diet to a high-carbohydrate diet requires several weeks (approximately 5-9 weeks) for full glycemic adaptation, meaning a 3-day preparation period is insufficient for accurate diabetes screening in habitual low-carb dieters.
If you have been eating a very low-carb diet and plan to switch to a higher-carb diet (or undergo a diabetes test), do not expect your blood sugar to stabilize immediately. It can take 5 to 9 weeks for your body to fully adapt to processing carbohydrates again. If you are getting a diabetes screening, inform your doctor about your recent low-carb diet history, as a standard 3-day prep may yield a false positive.
Physiological adaptation from a low- to high-carbohydrate diet may require many weeks, with implications for the accuracy of diabetes tests... If 3 days of consuming ≥150 g/day carbohydrate were adequate preparation for diabetes screening, then no changes in measures of glucose homeostasis would be expected after the first week following transition to the high-carbohydrate diets. However, data from CGM indicate significant downward trends from week 2 to week 9...
Why this rating
Randomized controlled feeding trial with continuous glucose monitoring, though stopped early due to COVID-19.
Source
Prolonged Glycemic Adaptation Following Transition From a Low- to High-Carbohydrate Diet: A Randomized Controlled Feeding Trial
Lisa T. Jansen et al. · Diabetes Care · 2022
DOI 10.2337/dc21-1970
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →